Coupling of a Signal Response Domain in IκBα to Multiple Pathways for NF-κB Activation

REFERENCES

• Alessi, D. R., Y. Saito, D. G. Campbell, P. Cohen, G. Sithanandam, U. Rapp, A. Ashworth, C. J. Marshall, and S. Cowley. 1994. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 13:1610–1619.
   PubMed Web of Science ®Google Scholar
• Andersson, S., D. L. Davis, H. Dahlback, H. Jörnvall, and D. W. Russell. 1989. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264:8222–8229.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53:211–217.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540–546.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P., and D. Baltimore. 1989. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev. 3:1689–1698.
   PubMed Web of Science ®Google Scholar
• Ballard, D. W., E. Böhnlein, J. W. Lowenthal, Y. Wano, B. R. Franza, and W. C. Greene. 1988. HTLV-I Tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 241:1652–1655.
   PubMed Web of Science ®Google Scholar
• Ballard, D. W., E. P. Dixon, N. J. Peffer, H. Bogerd, S. Doerre, B. Stein, and W. C. Greene. 1992. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc. Natl. Acad. Sci. USA 89:1875–1879.
   PubMedGoogle Scholar
• Ballard, D. W., W. H. Walker, S. Doerre, P. Sista, J. A. Molitor, E. P. Dixon, N. J. Peffer, M. Hannink, and W. C. Greene. 1990. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell 63:803–814.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., and A. S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064–2070.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301–3310.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasm retention. Genes Dev. 6:1899–1913.
   PubMed Web of Science ®Google Scholar
• Béraud, C., S.-C. Sun, P. Ganchi, D. W. Ballard, and W. C. Greene. 1994. Human T-cell leukemia virus type 1 tax associates with and is negatively regulated by the NF-κB2 p100 gene product: implications for viral latency. Mol. Cell. Biol. 14:1374–1382.
   PubMed Web of Science ®Google Scholar
• Blanar, M., and W. J. Rutter. 1992. Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-fos. Science 256:1014–1018.
   PubMedGoogle Scholar
• Böhnlein, E., J. W. Lowenthal, M. Siekevitz, D. W. Ballard, B. R. Franza, and W. C. Greene. 1988. The same inducible nuclear protein(s) regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type I HIV. Cell 53:827–836.
   PubMedGoogle Scholar
• Böhnlein, E., M. Siekevitz, D. W. Ballard, J. W. Lowenthal, L. Rimsky, H. Bogerd, J. Hoffman, Y. Wano, B. R. Franza, and W. C. Greene. 1989. Stimulation of human immunodeficiency virus type I enhancer by the human T-cell leukemia virus type I tax gene product involves the activation of inducible cellular proteins. J. Virol. 63:1578–1586.
   PubMedGoogle Scholar
• Bours, V., J. Villalobos, P. R. Burd, K. Kelly, and U. Siebenlist. 1990. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (London) 348:76–80.
   PubMed Web of Science ®Google Scholar
• Boyle, W., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110–149.
   PubMed Web of Science ®Google Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκBα. Proc. Natl. Acad. Sci. USA 90:2532–2536.
   PubMed Web of Science ®Google Scholar
• Cordle, S. R., R. Donald, M. A. Read, and J. Hawiger. 1993. Lipopolysac-charide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1. J. Biol. Chem. 268: 11803–11810.
   PubMed Web of Science ®Google Scholar
• Cross, S. L., M. B., Feinberg, J. B. Wolf, N. J. Holbrook, F. Wong-Staal, and W. J. Leonard. 1987. Regulation of the human interleukin-2 receptor α chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 49:47–56.
   PubMed Web of Science ®Google Scholar
• Davis, N., S. Ghosh, D. L. Simmons, P. Tempst, H. C. Liou, D. Baltimore, and H. R. Bose, Jr. 1991. Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science 253:1268–1271.
   PubMedGoogle Scholar
• deMartin, R., B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, H. Winkler, and F. H. Bach. 1993. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NF-κB. EMBO J. 12:2773–2779.
   PubMedGoogle Scholar
• Durand, D. B., M. R. Bush, J. G. Morgan, A. Weiss, and G. R. Crabtree. 1987. A 275 basepair fragment at the 59 end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J. Exp. Med. 165:395–407.
   PubMed Web of Science ®Google Scholar
• Frantz, B., E. C. Nordby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid, M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J. 13:861–870.
   PubMed Web of Science ®Google Scholar
• Fujii, H., H. Tsuchiya, T. Chuhjo, T. Akizawa, and M. Seiki. 1992. Interaction of HTLV-1 Tax with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev. 6:2066–2076.
   PubMed Web of Science ®Google Scholar
• Ganchi, P., S.-C. Sun, W. C. Greene, and D. W. Ballard. 1992. IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the trans-activation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell 3:1339–1352.
   PubMedGoogle Scholar
• Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019–1029.
   PubMed Web of Science ®Google Scholar
• Gilman, M. Z., R. N. Wilson, and R. A. Weinberg. 1986. Multiple protein-binding sites in the 59-flanking region regulate c-fos expression. Mol. Cell. Biol. 6:4305–4316.
   PubMed Web of Science ®Google Scholar
• Green, P. L., and I. S. Y. Chen. 1994. Molecular features of the human T-cell leukemia virus, p. 277–311. In J. A. Levy (ed.), The Retroviridae, vol. 3. Plenum Press, New York.
   Google Scholar
• Greene, W. C., E. Böhnlein, and D. W. Ballard. 1989. HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises. Immunol. Today 10:272–277.
   PubMedGoogle Scholar
• Grilli, M., J. Chiu, and M. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1–62.
   PubMed Web of Science ®Google Scholar
• Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281–1289.
   PubMed Web of Science ®Google Scholar
• Hatada, E., M. Naumann, and C. Scheidereit. 1993. Common structural constituents confer IκB activity to NF-κB p105 and IκB/MAD-3. EMBO J. 12:2781–2788.
   PubMedGoogle Scholar
• Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary in the activation of transcription factor NF-κB. Nature (London) 365:182–185.
   PubMed Web of Science ®Google Scholar
• Hirai, H., J. Fujisawa, T. Suzuki, K. Ueda, M. Muramatsu, A. Tsuboi, N. Arai, and M. Yoshida. 1992. Transcriptional activator Tax of HTLV-I binds to the NF-κB precursor p105. Oncogene 7:1737–1742.
   PubMed Web of Science ®Google Scholar
• Hirai, H., T. Suzuki, J. Fujisawa, J. Inoue, M. Yoshida. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA 91:3584–3588.
   PubMed Web of Science ®Google Scholar
• Inoue, J.-I., L. D. Kerr, A. Kakizuka, and I. M. Verma. 1992. IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 68:1109–1120.
   PubMed Web of Science ®Google Scholar
• Inoue, J.-I., L. D. Kerr, D. Rashid, N. Bose, Jr., and I. M. Verma. 1992. Direct association of pp40/IκBβ with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc. Natl. Acad. Sci. USA 89:4333–4337.
   PubMedGoogle Scholar
• Inoue, J.-I., M. Seiki, T. Taniguchi, S. Tsuru, and M. Yoshida. 1986. Induction of interleukin-2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I. EMBO J. 5:2883–2888.
   PubMed Web of Science ®Google Scholar
• Kang, S.-M., A. Chen-Tran, M. Grilli, and M. Leonardo. 1992. NF-κB subunit regulation in nontransformed CD41 T lymphocytes. Science 256: 1452–1456.
   PubMed Web of Science ®Google Scholar
• Kanno, T., K. Brown, G. Franzoso, and U. Siebenlist. 1994. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB. Mol. Cell. Biol. 14:6443–6451.
   PubMed Web of Science ®Google Scholar
• Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. LeBail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israël. 1990. The DNA binding subunit of NF-κB is identified to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007–1018.
   PubMed Web of Science ®Google Scholar
• Kimata, J. T., and L. Ratner. 1991. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J. Virol. 65:3134–3141.
   Google Scholar
• Kitajima, I., T. Shinohara, J. Bilakovics, D. A. Brown, X. Xu, and M. Nerenberg. 1992. Ablation of transplanted HTLV-1 Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258:1792–1795.
   PubMed Web of Science ®Google Scholar
• Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227–229.
   PubMed Web of Science ®Google Scholar
• Leung, K., and G. Nabel. 1988. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature (London) 333: 776–778.
   PubMed Web of Science ®Google Scholar
• Lowenthal, J., D. W. Ballard, E. Böhnlein, and W. C. Greene. 1989. Tumor necrosis factor alpha induces proteins that bind specifically to kB-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA 86:2331–2335.
   PubMedGoogle Scholar
• Lowenthal, J. W., E. Böhnlein, D. W. Ballard, and W. C. Greene. 1988. Regulation of interleukin-2 receptor α subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc. Natl. Acad. Sci. USA 85:4468–4472.
   PubMedGoogle Scholar
• Manger, B., A. Weiss, C. Weyand, J. Goronzy, and J. Stobo. 1985. T cell activation: differences in the signals required for IL-2 production by non-activated and activated T cells. J. Immunol. 135:3669–3673.
   PubMedGoogle Scholar
• Maruyama, M., H. Shibuya, H. Harada, M. Hatakeyama, M. Seiki, T. Fujita, J.-I. Inoue, M. Yoshida, and T. Taniguchi. 1987. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I-encoded p40x and T3/Ti complex triggering. Cell 48:343–350.
   PubMed Web of Science ®Google Scholar
• Mellits, K. H., R. T. Hay, and S. Goodbourn. 1993. Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21:5059–5066.
   PubMed Web of Science ®Google Scholar
• Mercurio, F., J. A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:705–718.
   PubMed Web of Science ®Google Scholar
• Meyer, R., E. N. Hatada, H.-P. Hohmann, M. Haiker, C. Bartsch, U. Roth-lisberger, H.-W. Lahm, E. J. Schlaeger, A. P. G. M. van Loon, and C. Scheidereit. 1991. Cloning of the DNA-binding subunit of human nuclear factor kB: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 88:966–970.
   PubMed Web of Science ®Google Scholar
• Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711–713.
   PubMed Web of Science ®Google Scholar
• Nakamaye, K., and F. Eckstein. 1986. Inhibition of restriction endonuclease Nci I cleavage by phosphothioate groups and its application to oligonucle-otide-directed mutagenesis. Nucleic Acids Res. 14:9679–9698.
   PubMed Web of Science ®Google Scholar
• Naumann, M., and C. Scheidereit. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 13:4597–4607.
   PubMed Web of Science ®Google Scholar
• Naumann, M., F. G. Wulczyn, and C. Sheidereit. 1993. The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-KB. EMBO J. 12:213–222.
   PubMedGoogle Scholar
• Neumann, J., C. Morency, and K. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques 5:444–447.
   Web of Science ®Google Scholar
• Nolan, G. P., S. Ghosh, H.-C. Lion, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961–969.
   PubMed Web of Science ®Google Scholar
• Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor-kappa B. Proc. Natl. Acad. Sci. USA 86: 2336–2340.
   PubMed Web of Science ®Google Scholar
• Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. Ubiquitin and the proteasome are required for processing the NF-κB1 precursor and the activation of NF-κB. Cell 78:773–785.
   PubMed Web of Science ®Google Scholar
• Pearson, R. B., and B. E. Kemp. 1991. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol. 200:62–81.
   PubMed Web of Science ®Google Scholar
• Prickett, K. S., D. C. Amberg, and T. P. Hopp. 1989. A calcium-dependent antibody for identification and purification of recombinant proteins. Bio-Techniques 7:580–589.
   Google Scholar
• Rice, N. R., M. L. MacKichan, and A. Israël. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243–253.
   PubMedGoogle Scholar
• Rogers, S., R. Wells, and M. Rechsteiner. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364–368.
   PubMed Web of Science ®Google Scholar
• Ruben, S. M., P. J. Dillon, R. Schreck, T. Henkel, C.-H. Chen, M. Maher, P. A. Baeuerle, and C. A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the p65-kD subunit of NF-κB. Science 251:1490–1493.
   PubMedGoogle Scholar
• Ruben, S. M., R. Narayanan, J. Klement, C.-H. Chen, and C. Rosen. 1992. Functional characterization of the NF-κB p65 transcriptional activator and an alternatively sliced derivative. Mol. Cell. Biol. 12:444–454.
   PubMedGoogle Scholar
• Ruben, S. M., H. Poteat, T. H. Tan, K. Kawakami, R. Roeder, W. Haseltine, and C. A. Rosen. 1988. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-1 tax gene product. Science 241:89–92.
   PubMed Web of Science ®Google Scholar
• Schmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805–3817.
   PubMed Web of Science ®Google Scholar
• Schreck, R., R. Grassman, B. Fleckenstein, and P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type I Tax protein. J. Virol. 66:6288–6293.
   PubMed Web of Science ®Google Scholar
• Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247–2258.
   PubMed Web of Science ®Google Scholar
• Schreiber, E., P. Matthias, M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res. 17:6419.
   PubMed Web of Science ®Google Scholar
• Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. 1992. TNF activates NF-κB by phosphatidylcholine-specific phos-pholipase C-induced ‘‘acidic’’ sphingomyelin breakdown. Cell 71:765–776.
   PubMed Web of Science ®Google Scholar
• Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705–716.
   PubMed Web of Science ®Google Scholar
• Siekevitz, M., M. B. Feinberg, N. Holbrook, F. Wong-Staal, and W. C. Greene. 1987. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the transactivator (tat) gene product of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 84:5389–5393.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., and W. C. Greene. 1990. Identification of HTLV-1 tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875–1885.
   PubMed Web of Science ®Google Scholar
• Sodroski, J., C. Rosen, W. C. Goh, and W. Haseltine. 1985. A transcriptional activator protein encoded by the x-lor region of human T cell leukemia virus. Science 228:1430–1434.
   PubMed Web of Science ®Google Scholar
• Stein, B., H. Rahmsdorf, A. Steffen, M. Litfin, and P. Herrlich. 1989. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-Fos, and metallothio-nein. Mol. Cell. Biol. 9:5169–5181.
   PubMed Web of Science ®Google Scholar
• Sun, S.-C., P. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregula-tory pathway. Science 259:1912–1915.
   PubMed Web of Science ®Google Scholar
• Sun, S.-C., P. Ganchi, C. Béraud, D. W. Ballard, and W. C. Greene. 1994. Autoregulation of the NF-κB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA 91:1346–1350.
   PubMed Web of Science ®Google Scholar
• Sun, S.-C., J. Elwood, C. Béraud, and W. C. Greene. 1994. Human T-cell leukemia virus type I tax activation of NF-κB/Rel involves phosphorylation and degradation of IκBα and RelA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol. 14:7377–7384.
   PubMedGoogle Scholar
• Suzuki, T., J. I. Fujisawa, M. Toita, and M. Yoshida. 1993. The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc. Natl. Acad. Sci. USA 90:610–614.
   PubMed Web of Science ®Google Scholar
• Ten, R. M., C. V. Paya, N. Israel, O. LeBail, M. G. Mattei, J. L. Virelizier, P. Kourilsky, and A. Israël. 1992. The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J. 11:195–203.
   PubMed Web of Science ®Google Scholar
• Tewari, M., P. Dobrzanski, K. L. Mohn, D. E. Cressman, J. C. Hsu, R. Bravo, and R. Taub. 1992. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site binding complex. Mol. Cell. Biol. 12:2898–2908.
   PubMed Web of Science ®Google Scholar
• Urban, M., and P. Baeuerle. 1990. The 65-kD subunit of NF-κB is a receptor for IκB and a modulator of DNA-binding specificity. Genes Dev. 4:1975–1984.
   PubMedGoogle Scholar
• Watanabe, M., M.-A. Muramatsu, H. Hirai, T. Suzuki, J. Fujisawa, M. Yoshida, K.-I. Arai, and N. Arai. 1993. HTLV-I encoded Tax in association with NF-κB precursor p105 enhances nuclear localization of NF-κB p50 and p65 in transfected cells. Oncogene 8:2949–2958.
   PubMedGoogle Scholar
• Weiss, A., and D. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263–274.
   PubMed Web of Science ®Google Scholar
• Zhao, L. J., and C. Z. Giam. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interactions. Proc. Natl. Acad. Sci. USA 89:7070–7074.
   PubMed Web of Science ®Google Scholar